Images List Premium Download Classic

Allergy

Allergy-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Automatic decision support
Mmodal Ip Llc
June 14, 2018 - N°20180166081

Speech is transcribed to produce a transcript. At least some of the text in the transcript is encoded as data.
Methods of obtaining mononuclear blood cells and uses thereof
Biolinerx Ltd.
June 14, 2018 - N°20180161366

Methods of obtaining mononuclear blood cells are provided. Also provided are methods of using the obtained cells for treating diseases such as cancer, infectious disease, autoimmune disease, allergy, and graft rejection..
Sirp polypeptide compositions and methods of use
Ab Initio Biotherapeutics, Inc.
June 07, 2018 - N°20180155405

Provided herein are sirp-gamma, sirp-beta or sirp-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.. .
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Peptide derivative for regulating thymic stromal lymphoid protein-mediated signaling and pharmaceutical composition for preventing and ...
Korea University Research And Business Foundation, Sejong Campus
May 31, 2018 - N°20180148474

The present invention relates to a peptide derivative for regulating the thymic stromal lymphoid protein-mediated signaling and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases and, more particularly, to a peptide derivative represented by chemical formula 1 and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases. According ...
Allergy vaccine composition
Nitto Denko Corporation
May 31, 2018 - N°20180147235

The present invention provides an allergy vaccine composition that is useful as a prophylactic or therapeutic agent for an allergic disease and can safely and effectively induce immune tolerance. The vaccine composition is to be administered to a human or animal with an allergic disease for the prevention or treatment of the allergic disease.
Method for examining food allergy and examination kit
The University Of Tokyo
May 17, 2018 - N°20180136241

An object of the present invention is to provide an examination method for simply and properly evaluating the risk of developing food allergy and seriousness of the symptoms of allergy. The present invention provides a method for examining food allergy in a subject, including a step of measuring urinary tetranor-pgdm amount of the subject..
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Prime-boost regimens involving administration of at least one mrna construct
Curevac Ag
May 10, 2018 - N°20180125952

The present invention relates to prime-boost regimens that involve the administration of at least one mrna construct, such as the use of such constructs in “boost” administration subsequently to “prime” administration of certain other antigenic composition(s). Such inventive regimens may, in particular, be useful for the induction of an immune response ...
Immunoconjugates for programming or reprogramming of cells
President And Fellows Of Harvard College
May 03, 2018 - N°20180117171

The conjugate compositions and methods are useful to elicit/augment an immune response to a tumor or microbial infection or to reduce the severity of autoimmunity, chronic inflammation, allergy, asthma, periodontal disease, and transplant rejection.. .
Therapeutic microbiota for the treatment and/or prevention of food allergy
Children's Medical Center Corporation
May 03, 2018 - N°20180117099

Disclosed are methods and compositions for the prevention and treatment of food allergy. In particular, described herein are microbial consortia, including minimal microbial consortia, that can prevent and/or cure food allergy.
Therapeutic microbiota for the treatment and/or prevention of food allergy
Children's Medical Center Corporation
May 03, 2018 - N°20180117098

Disclosed are methods and compositions for the prevention and treatment of food allergy. In particular, described herein are microbial consortia, including minimal microbial consortia, that can prevent and/or cure food allergy.
Therapeutic microbiota for the treatment and/or prevention of food allergy
Children's Medical Center Corporation
May 03, 2018 - N°20180117097

Disclosed are methods and compositions for the prevention and treatment of food allergy. In particular, described herein are microbial consortia, including minimal microbial consortia, that can prevent and/or cure food allergy.
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
Regeneron Pharmaceuticals, Inc.
April 05, 2018 - N°20180094070

The present invention provides methods for treating, preventing or reducing the severity of allergic reactions. The present invention also provides methods for enhancing the efficacy and/or safety of an allergen-specific immunotherapy (sit) regimen.
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
Regeneron Pharmaceuticals, Inc.
April 05, 2018 - N°20180094069

The present invention provides methods for treating, preventing or reducing the severity of allergic reactions. The present invention also provides methods for enhancing the efficacy and/or safety of an allergen-specific immunotherapy (sit) regimen.
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Anti-human vista antibodies and use thereof
Janssen Pharmaceuticals, Inc.
March 22, 2018 - N°20180079811

The invention provides antagonistic and agonistic anti-human vista antibodies and antibody fragments. These antagonist antibodies and antibody fragments may be used to inhibit or block vista's suppressive effects on t cell immunity and thereby promote t cell immunity.
Novel compound useful for the treatement of degenerative and inflammatory diseases
March 22, 2018 - N°20180078547

A pyrazolopyridine compound according to formula i, able to inhibit jak is disclosed, as well as pharmaceutically acceptable salts, a solvate thereof, solvates of the pharmaceutically acceptable salts and biologically active metabolites thereof. The compound may be prepared as a pharmaceutical composition, and may be used for the treatment or prophylaxis of a variety of conditions in mammals including humans, ...
Treatment method for improving intestinal enviornment and intestinal tract barrier
March 15, 2018 - N°20180071237

Provided is a treatment method for improving intestinal environment and intestinal tract barrier, the treatment method including: a process of measuring a value of specific ig g to a food antigen inducing delayed food allergy of a patient of each food in a case where the patient has inflammation caused by local or systemic antigen-antibody reaction; a process of deriving ...
Anti-il-25 antibodies and uses thereof
Regeneron Pharmaceuticals, Inc.
March 01, 2018 - N°20180057583

The present invention provides antibodies that bind to human interleukin-25 (il-25) and methods of using the same. According to certain embodiments, the antibodies of the invention bind human il-25 with high affinity.
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory ...
King's College London
February 22, 2018 - N°20180051070

The present invention relates to a fusion proteins comprising regulatory t cell protein, vista (v-domain immunoglobulin suppressor of t cell activation (pd-l3) and an immunoglobulin protein (ig), preferably also containing a flexible linker intervening the vista and ig fc polypeptide. The invention also provides the use of vista polypeptides, multimeric vista polypeptides, vista-conjugates (e.g., vista-ig), and vista antagonists for ...
Bacterial compositions and methods of use thereof
The University Of British Columbia
February 22, 2018 - N°20180050070

The present invention relates to bacterial compositions and methods of use thereof. The bacterial compositions may include two or more bacteria of the genera faecalibacterium, lachnospira, veillonella or rothia.
Methods and compositions to reduce peanut-induced anaphylaxis
February 15, 2018 - N°20180044384

The present disclosure provides compositions comprising recombinant bacterial spores. The present disclosure is also directed to vaccine based compositions, which include recombinant bacterial spores that express ctb and a peanut protein(s) on their surfaces.
Devices and methods for applying antigens for allergy testing
February 08, 2018 - N°20180036020

Devices and methods for applying antigens for allergy testing. In certain embodiments the device comprises an elongated body comprising a first end and a second end and a curved lower surface extending between the first and second ends.
Loading